Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2008
10/08/2008CN100424179C Process for preparing insulin compounds
10/08/2008CN100424176C Ginseng tonolast aquaporin gene, its coded amino acid sequence and use
10/08/2008CN100424175C Methods and compositions for treating neoplasms by ERBB3
10/08/2008CN100424096C Survivin mutant containing HIV transduction structural area and its preparation method and uses
10/08/2008CN100424094C Pharmaceutical compositions, and a method of preparing and isolating said pharmaceutical compositions, and use of said pharmaceutical compositions for prophylactic treatment of lesions and carcinomas
10/07/2008US7433788 Crystallization of IGF-1
10/07/2008US7432419 Compositions and methods for the treatment of Pierce's disease
10/07/2008US7432418 Seed-preferred regulatory elements and uses thereof
10/07/2008US7432417 Generation of plants with improved pathogen resistance
10/07/2008US7432416 Introducing into plant progenitor cells a vector comprising a nucleotide sequence, growing the transformed cells to produce a transgenic plant
10/07/2008US7432414 Drug screening; Alzheimer's disease; novel cleavage site provides a superior in vivo substrate for beta secretase than the wild type substrate
10/07/2008US7432367 Diagnosis of diseases related to an alteration in the regulation or in the coding regions of the RBP-7 gene and for prognosis/diagnosis of an eventual treatment with agents acting on pathologies involving abnormal cell proliferation and/or abnormal cell differentiation.
10/07/2008US7432366 Moraxella catarrhalis BASB034 polypeptides and used thereof
10/07/2008US7432363 Ly6H gene
10/07/2008US7432361 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
10/07/2008US7432360 Containing 0.001 to 0.01% w/v benzethonium chloride and 0.01 to 0.5% w/v phenoxyethanol or 0.01 to 0.5% w/v phenylethyl alcohol as preservatives; vials for parenteral administration
10/07/2008US7432358 Oncogene, recombinant protein derived therefrom, and uses thereof
10/07/2008US7432355 identifying an agent that reduces the lipid binding activity of an apoE stable folding intermediate, the method comprising by contacting an apoE stable folding intermediate in a solution with a test agent and determining the effect
10/07/2008US7432354 Polypeptide or fragment recognized by tumor-specific cytotoxic T lymphocytes; anticancer vaccines
10/07/2008US7432353 Biosensor with increased signal intensity to sugar concentration that is a maltose binding protein bound to enhanced cyan, enhanced blue, or enhanced green fluorescent protein on one end and enhanced yellow, enhanced green, or red fluorescent protein on the other through dipeptide linkages
10/07/2008US7432351 B7-H1 variants
10/07/2008US7432350 Recombinant biotin carboxylase domains for identification of Acetyle CoA carboxylase inhibitors
10/07/2008US7432349 Tumor suppressor proteinfor use as tool in diagnosis, prevention and treatment of cell proliferative disorders
10/07/2008US7432348 Novel Protein Histidine Phosphatase Interacting Partner of 180 KD; polypeptides/polynucleotides in diagnostic assays;genetic engineering; identifying agonists and antagonists; conditions having PHPIP-180 imbalance; cardiovascular diseases; nervous system disorders; antitumor, - carcinogenic agents
10/07/2008US7432347 Cytoplasmic polyhedrosis virus polyhedrin protein complex
10/07/2008US7432346 Gene expressed in prostate cancer
10/07/2008US7432345 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
10/07/2008US7432344 Porcine CTLA-4 for xenograft-specific immunosuppression
10/07/2008US7432342 Kinase anchor protein muteins, peptides thereof and related documents
10/07/2008US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas
10/07/2008US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent
10/07/2008US7432242 Inhibitors of RGS proteins
10/07/2008US7432240 Fumaric acid amides
10/07/2008US7432237 Methods of treating asthma by administering interleukin-17 receptor
10/07/2008US7432236 Vasostatin as marrow protectant
10/07/2008US7432098 Polypeptide of given sequence encoding signal peptide; thermal stability; improves nutritional value of foodstuffs
10/07/2008US7432097 Phytases, nucleic acids encoding them and methods of making and using them
10/07/2008US7432093 Soluble, functional apoptotic protease-activating factor 1 fragments
10/07/2008US7432092 Orthogonal aminoacyl-tRNA synthetase of given amino acid sequence; aminoacylates with p-acetyl-L-phenylalanine; insertion into polypeptide in response to selector codons
10/07/2008US7432081 Nucleotide sequences coding protein for use the prevention of bacterial infections
10/07/2008US7432079 Antigenic peptide fragments of growth differentiation factor 8, and related immunogens, vaccines; Immunization; drug screening
10/07/2008US7432078 can be applied to assay systems for evaluating the ability of chemical substances to regulate receptor activity
10/07/2008US7432077 High-affinity choline transporter
10/07/2008US7432067 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility
10/07/2008US7432065 Microarray for identifying regulator peptides which bind and regulate modular protein domain (PDZ) interactions with hematopoietic cells for use in treatment of autoimmune, cell proliferative and nervous system disorders; peptide mimetics
10/07/2008US7432064 Using cancer specific gene expression as tool in detection, classification and treament of cell proliferative disorders; immunodiagnostics
10/07/2008US7432062 Screening methods using B7-H2 molecules, members of the B7 family
10/07/2008US7432061 Assays for measuring matrix metalloproteinase activities
10/07/2008US7432059 Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal
10/07/2008US7432057 Amplifying genomic nucleic acid with primers and visualizing on gel for genotyping; better meat quality, higher postmortem pH and better water holding capacity
10/07/2008US7432053 Fluorescent protein from Aequorea coerulscens and methods for using the same
10/07/2008US7432052 Method and identification of downstream mRNA ligands to FMRP and their role in fragile X syndrome and associated disorders
10/07/2008US7432051 Detecting solid breast tumor by measuring polypeptide or mRNA from sample; administering an antagonist to inhibit cell proliferation
10/07/2008US7432047 Method for selective inactivation of viral replication
10/07/2008US7432045 Membrane transiting peptides having antiviral properties; respiratory disorders
10/07/2008US7431936 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
10/07/2008US7431935 Clostridium botulinum neurotoxin for treating spasticity associated with brain ischemia, or traumatic injury of the brain or spinal cord, tension hedache or pain and disorders associated with excessive release of acetylcholine for neuronal tissues
10/07/2008US7431934 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
10/07/2008US7431933 Viricide resistant hepatitis b; drug design and screening; genetic vaccines
10/07/2008US7431930 Neutralizing epitopes for viruses
10/07/2008US7431929 For eliciting an immune response to smallpox virus ; vaccines having an increased level of safety, recombinant vaccinia viruses containing an inactivated E3L region
10/07/2008US7431928 Immunogenic peptide of given amino acid sequence incorporated in support or carrier; isolating human leukocyte antigen cells from lymphoid or myeloid cells; induction of cytotoxic response
10/07/2008US7431926 Tumor supressor gene p33ING2
10/07/2008US7431924 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
10/07/2008US7431921 Interferon beta-like molecules
10/07/2008CA2388910C Antimicrobial activity of the first cationic cluster of human lactoferrin
10/07/2008CA2296067C Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
10/07/2008CA2286366C Transgenic expression in genital tract and sexual accessory glands
10/07/2008CA2264496C Fungal antigens and process for producing the same
10/07/2008CA2237296C Process for the preparation of peptides by way of streptavidin fusion proteins
10/07/2008CA2224126C Enhanced protein production method
10/07/2008CA2223449C Peptides and compounds that bind to the thrombopoietin receptor
10/07/2008CA2218515C Monoclonal antibodies against hiv-1 and vaccines made thereof
10/07/2008CA2173956C Dna encoding 1,3-beta-d glucan synthase subunits
10/07/2008CA2149319C Haemophilus outer membrane protein
10/07/2008CA2148563C Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain
10/07/2008CA2106061C Human follicle stimulating hormone receptor
10/07/2008CA2087494C Soluble ldl receptor, its production and use
10/07/2008CA1341582C Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
10/02/2008WO2008118930A1 Soluble il-17ra/rc fusion proteins and related methods
10/02/2008WO2008118847A1 Composition and method for treating cancer
10/02/2008WO2008118545A2 Methods for generating novel stabilized proteins
10/02/2008WO2008118507A2 Recombinant human factor ix and use thereof
10/02/2008WO2008118497A1 Rhadinovirus vectors for expressing of immunodeficiency virus antigen
10/02/2008WO2008118350A1 Compositions and methods of using crmp-1 and its fragments for treating cancer
10/02/2008WO2008118167A1 Method for forming molecular sequences on surfaces
10/02/2008WO2008118094A1 Thin metal nanowires produced by biotemplating
10/02/2008WO2008118090A1 Cartilage intermediate layer protein 2 c1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
10/02/2008WO2008118087A1 Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions
10/02/2008WO2008118017A2 Prame derived peptides and immunogenic compositions comprising these
10/02/2008WO2008118015A2 Improved vaccines against bordetella pertussis based on lps glycosyltransferase mutants
10/02/2008WO2008117792A1 Fluorescent labeled fused protein for assaying adenosine triphosphate
10/02/2008WO2008117561A1 Protein with sweet taste
10/02/2008WO2008117179A2 Polynucleotides and polypeptides of human factor vii gene, snps
10/02/2008WO2008116775A1 Polypeptide recognized by anti hiv-1 gp41 antibodies isolated from highly hiv-1 exposed, non infected women
10/02/2008WO2008116715A1 Aerated food products being warm or having been heated up and methods for producing them
10/02/2008WO2008116648A2 Novel glp-1 fusion peptides, their production and use
10/02/2008WO2008116468A2 Mhc peptide complexes and uses thereof in infectious diseases
10/02/2008WO2008116368A1 A method for preparing antigens of foot-and-mouth disease virus
10/02/2008WO2008116316A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells